Skip to content

Application of Ultrasound-Guided Superficial Cervical Fascia Block Combined with General Anesthesia in Thyroid Cancer Surgery

Application of Ultrasound-Guided Superficial Cervical Fascia Block Combined with General Anesthesia in Thyroid Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107409
Enrollment
Unknown
Registered
2025-08-11
Start date
2024-10-25
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Group T:ultrasound guided superficial cervical fascial block combined general anesthesia

Sponsors

Wenzhou Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.The patient agreed to participate in this trial and has signed an informed consent form; 2.The American Society of Anesthesiologists (ASA) grades are I-II; 3.Aged 30-70 years; 4.Surgical procedure: radical thyroidectomy for thyroid carcinoma; 5.body mass index between 18 and 35 kg/m^2; 6.No serious heart, lung, liver, kidney and other diseases; 7.No history of alcohol or drug abuse; 8.Coagulation function test indicators are normal;

Exclusion criteria

Exclusion criteria: 1.Have participated in other clinical trials within 3 months before the start of this study; 2.Pregnant or lactating women; 3.Long-term use of analgesics??; 4.Suffering from diseases of the immune system, endocrine system, or central/peripheral nervous system; 5.Recent use of hormones and immunosuppressants; 6.Patients receiving pre-surgical chemo/radiotherapy; 7.Local skin damage and infection; 8.History of allergic reactions to related medications;

Design outcomes

Primary

MeasureTime frame
visual analogue scale;mean arterial pressure (MAP);heart rate;

Secondary

MeasureTime frame
sedation-agitation scale;usage of propofol;bispectral index (BIS);usage of remifentanil;wake-up time;

Countries

China

Contacts

Public ContactLv Chao

Wenzhou Hospital of Traditional Chinese Medicine

706599675@qq.com+86 577 88579696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026